Major Insider Move: Cellebrite DI CEO Executes High-Value Stock Sale
I'm LongbridgeAI, I can summarize articles.Cellebrite DI CEO Hogan Thomas E. sold 139,713 shares worth $2.15 million on August 13, 2026. Concurrently, Shiven Ramji was promoted to CEO, focusing on AI and cloud platforms. While H1 2026 financials showed strong margins and cash flow, management trimmed ARR and revenue outlooks due to slower adoption, though EBITDA targets were raised. TipRanks' Spark AI rates CLBT as an 'Outperform', citing robust financial quality and AI catalysts, despite a rich valuation of ~54 P/E.
New insider activity at Cellebrite DI ( (CLBT) ) has taken place on August 13, 2026.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Cellebrite DI’s CEO, Hogan Thomas E., has sold 139,713 shares of the company’s stock in a transaction valued at $2,148,785, signaling a significant move in the executive’s personal holdings and drawing attention from investors monitoring insider activity.
Recent Updates on CLBT stock
Cellebrite DI shares reacted to August 13 updates centered on leadership succession and mixed guidance. The company promoted product and technology chief Shiven Ramji to CEO, signaling a stronger focus on AI, cloud and subscription platforms, while outgoing CEO Thomas Hogan remains an advisor to preserve strategic continuity.
Financial filings for H1 and Q2 2026 showed solid revenue and ARR growth, strong margins and free cash flow, but also longer sales cycles and slower Inseyets adoption that led management to trim full‑year ARR and revenue outlook while raising EBITDA targets. Analysts’ higher price expectations appear driven by this combination of robust financial quality and expanding AI and cloud product catalysts, partially offset by valuation richness and moderating growth trends.
Over the last 24 hours, these developments framed market sentiment more around Cellebrite’s ability to sustain subscription‑led expansion and monetize new platforms such as Genesis AI, Guardian SaaS and FedRAMP-backed government cloud services than around short-term volatility. The focus of target revisions is on improved profitability, balance-sheet strength and product-led strategy, weighed against execution risks in a competitive digital forensics and intelligence market.
Spark’s Take on CLBT Stock
According to Spark, TipRanks’ AI Analyst, CLBT is a Outperform.
The score is driven primarily by strong financial quality (high margins, robust free cash flow, low leverage) and a positive earnings-call setup (guidance for ARR acceleration plus strategic catalysts like AI products and FedRAMP). Offsetting factors are a rich valuation (P/E ~54) and technical indicators that are strong but near overbought, alongside the fundamental risk of slowing recent revenue growth versus prior periods.
To see Spark’s full report on CLBT stock,
click here.
More about Cellebrite DI
YTD Price Performance: -15.42%
Average Trading Volume: 1,949,527
Technical Sentiment Signal: Buy
Current Market Cap: $4B